MATTHEW ANGEL
Profile
First Name
: MATTHEW
Middle Name
:
Last Name
: ANGEL
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
TERRY BATEMAN, JEFF BERG, KENDRA BERGER, BRANT BINDER, JAMES BRISTOL, BARRY CHANDLER, CHARLES CHERINGTON, PETER CICALA, DOROTHY CLARKE, KEVIN D-AMOUR, ERIN S. ENRIGHT, JOSEPH J. FARRICIELLI, JR., HOWARD J. FEDEROFF, GREGORY FIORE, SANDRA GURROLA, ANDREW JACKSON, KENNETH L. KEYMER, VLADIMIR KHUCHUA-EDELMAN, DENNIS LANGER, MARY BETH LEWIS, SANJEEV LUTHER, STEVE MITGANG, ERICH MOHR, KIRK NAGAMINE, ELENA RATNER, HEATHER B. REDMAN, JAY SIAL, ROGER SIDHU, NICHOLAS J. SINGER, TONY UPHOFF, RICHARD W. WAGNER, WILLIAM WEXLER, PAUL YANOVER
EXECUTIVE OFFICER, DIRECTOR
RICHARD ALDRICH, CHRISTOPHER A. BLECK, STEPHEN BRADY, STEPHEN R. BRADY, JEFF CAPELLO, SCOTT CHAPPEL, MICHELLE DIPP, THOMAS W. DUBENSKY, MICHAEL FLANAGAN, STEPHEN KRAUS, ALISON LAWTON, NICHOLAS MAESTAS, THOMAS MALLEY, GEOFFREY NICHOL, CHRISTINE PELLIZZARI, MICHAEL RAAB, WILLIAM DRAKE RICHEY, RONIT SIMANTOV, JOHN SIMON, HARALD STOCK, JONATHAN TILLY, JUSTIN TROJANOWSKI, CHRISTOPH WESTPHAL, THOMAS WOIWODE, JOHN DAVID YEE
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2026-05-29
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
NO REVENUES
Equity, Debt
2023-12-15
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity, Debt
2023-07-14
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity, Debt
2023-07-14
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-12-02
